Virological efficacy of abacavir: systematic review and meta-analysis | Zendy

Mario Cruciani | Zendy; Carlo Mengoli | Zendy; Marina Malena | Zendy; Giovanni Serpelloni | Zendy; Saverio Giuseppe Parisi | Zendy; Graeme Moyle | Zendy; Oliviero Bosco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Virological efficacy of abacavir: systematic review and meta-analysis

Author(s) -

Mario Cruciani,

Carlo Mengoli,

Marina Malena,

Giovanni Serpelloni,

Saverio Giuseppe Parisi,

Graeme Moyle,

Oliviero Bosco

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku279

Subject(s) - abacavir , emtricitabine , lamivudine , medicine , meta analysis , tenofovir , randomized controlled trial , human immunodeficiency virus (hiv) , virology , chronic hepatitis , virus

The efficacy of abacavir/lamivudine has been reported to be inferior to tenofovir/emtricitabine. Several randomized clinical trials (RCTs) investigated the effectiveness and safety of abacavir/lamivudine and tenofovir/emtricitabine combined antiretroviral treatment (cART) and we have reviewed the available evidence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research